Natus Medical Inc. (NASDAQ:BABY) insider James B. Hawkins purchased 10,000 shares of the stock in a transaction that occurred on Wednesday, September 28th. The stock was bought at an average price of $38.48 per share, with a total value of $384,800.00. Following the completion of the acquisition, the insider now owns 459,725 shares in the company, valued at approximately $17,690,218. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Natus Medical Inc. (NASDAQ:BABY) opened at 39.29 on Monday. The stock’s 50 day moving average price is $40.41 and its 200 day moving average price is $36.82. The firm has a market capitalization of $1.27 billion, a P/E ratio of 33.87 and a beta of 0.78. Natus Medical Inc. has a 52 week low of $29.54 and a 52 week high of $51.05.
Natus Medical (NASDAQ:BABY) last posted its quarterly earnings data on Wednesday, July 20th. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Natus Medical had a net margin of 10.20% and a return on equity of 13.82%. The firm had revenue of $96 million for the quarter, compared to analysts’ expectations of $92.71 million. During the same period in the previous year, the company posted $0.34 EPS. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. On average, analysts predict that Natus Medical Inc. will post $1.58 EPS for the current fiscal year.
Several analysts recently issued reports on the company. Zacks Investment Research downgraded Natus Medical from a “buy” rating to a “hold” rating in a report on Wednesday, September 28th. Raymond James Financial Inc. upgraded Natus Medical from a “market perform” rating to an “outperform” rating and set a $46.00 price target for the company in a report on Tuesday, September 13th.
A number of institutional investors have recently bought and sold shares of the company. Clinton Group Inc. raised its stake in shares of Natus Medical by 0.7% in the second quarter. Clinton Group Inc. now owns 8,614 shares of the company’s stock worth $326,000 after buying an additional 64 shares during the period. PineBridge Investments L.P. raised its stake in shares of Natus Medical by 3.7% in the second quarter. PineBridge Investments L.P. now owns 4,200 shares of the company’s stock worth $159,000 after buying an additional 149 shares during the period. Suntrust Banks Inc. raised its stake in shares of Natus Medical by 3.7% in the second quarter. Suntrust Banks Inc. now owns 5,776 shares of the company’s stock worth $218,000 after buying an additional 204 shares during the period. Arizona State Retirement System raised its stake in shares of Natus Medical by 1.8% in the second quarter. Arizona State Retirement System now owns 17,206 shares of the company’s stock worth $650,000 after buying an additional 300 shares during the period. Finally, Invictus RG raised its stake in shares of Natus Medical by 8.7% in the second quarter. Invictus RG now owns 4,200 shares of the company’s stock worth $159,000 after buying an additional 336 shares during the period. Hedge funds and other institutional investors own 87.92% of the company’s stock.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.